amgen said it has started preparing for a $ 50million offering of subordinated convertible debentures to investors overseas mainly in europe a convertible debenture is an unsecured bond that ultimately may be exchanged for stock in a company amgen a thousand oaks biotechnology company is being assisted in preparing the offering by morgan stanley international earlier this month the us food and drug administration approved the sale of amgens biotechnology drug erythropoietin a longawaited protein that treats chronic anemia in patients with kidney disease